Donna L. Barnd

1.5k total citations
9 papers, 1.2k citations indexed

About

Donna L. Barnd is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Donna L. Barnd has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Molecular Biology and 2 papers in Virology. Recurrent topics in Donna L. Barnd's work include Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (6 papers) and T-cell and B-cell Immunology (4 papers). Donna L. Barnd is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (6 papers) and T-cell and B-cell Immunology (4 papers). Donna L. Barnd collaborates with scholars based in United States, France and Italy. Donna L. Barnd's co-authors include Olivera J. Finn, Michael S. Lan, Richard S. Metzgar, Ian F. C. McKenzie, Katharine M. Bendt, Cinda M. Boyer, Joyce Taylor‐Papadimitriou, Keith R. Jerome, Robert C. Bast and William W. Grosh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Donna L. Barnd

9 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna L. Barnd United States 8 1000 699 428 328 57 9 1.2k
Gabriele Pecher Germany 17 810 0.8× 591 0.8× 553 1.3× 316 1.0× 114 2.0× 45 1.2k
I F McKenzie Australia 19 511 0.5× 522 0.7× 188 0.4× 410 1.3× 77 1.4× 45 995
Oscar Kashala United States 17 351 0.4× 451 0.6× 352 0.8× 169 0.5× 23 0.4× 27 866
Verena Rubio‐Godoy Switzerland 20 1.8k 1.8× 644 0.9× 872 2.0× 150 0.5× 71 1.2× 23 2.0k
N M Avdalovic United States 9 361 0.4× 472 0.7× 212 0.5× 585 1.8× 54 0.9× 9 1.0k
Malaya Bhattacharya‐Chatterjee United States 25 1.2k 1.2× 783 1.1× 620 1.4× 677 2.1× 89 1.6× 45 1.6k
Angela L. Zarling United States 13 837 0.8× 565 0.8× 304 0.7× 177 0.5× 44 0.8× 17 1.1k
Stefan Stevanović Germany 15 929 0.9× 596 0.9× 270 0.6× 161 0.5× 65 1.1× 27 1.3k
G. A. Pietersz Australia 11 480 0.5× 401 0.6× 166 0.4× 261 0.8× 31 0.5× 20 678
Cees J. M. Melief Netherlands 9 801 0.8× 472 0.7× 322 0.8× 67 0.2× 108 1.9× 11 1.3k

Countries citing papers authored by Donna L. Barnd

Since Specialization
Citations

This map shows the geographic impact of Donna L. Barnd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna L. Barnd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna L. Barnd more than expected).

Fields of papers citing papers by Donna L. Barnd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna L. Barnd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna L. Barnd. The network helps show where Donna L. Barnd may publish in the future.

Co-authorship network of co-authors of Donna L. Barnd

This figure shows the co-authorship network connecting the top 25 collaborators of Donna L. Barnd. A scholar is included among the top collaborators of Donna L. Barnd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna L. Barnd. Donna L. Barnd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Slingluff, Craig L., Gina R. Petroni, Galina V. Yamshchikov, et al.. (2004). Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule. Journal of Clinical Oncology. 22(22). 4474–4485. 111 indexed citations
2.
Woodson, Elizabeth M. H., Kimberly A. Chianese‐Bullock, Eric A. Bissonette, et al.. (2004). Assessment of the Toxicities of Systemic Low-Dose Interleukin-2 Administered in Conjunction with a Melanoma Peptide Vaccine. Journal of Immunotherapy. 27(5). 380–388. 10 indexed citations
3.
Slingluff, Craig L., Gina R. Petroni, Galina V. Yamshchikov, et al.. (2003). Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells. Journal of Clinical Oncology. 21(21). 4016–4026. 252 indexed citations
4.
Yamshchikov, Galina V., Donna L. Barnd, James W. Patterson, et al.. (2001). Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients. International Journal of Cancer. 92(5). 703–711. 99 indexed citations
5.
Yamshchikov, Galina V., Donna L. Barnd, Donna H. Deacon, et al.. (2001). Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients. International Journal of Cancer. 92(5). 703–711. 2 indexed citations
6.
Hosmalin, Anne, Sanjeev Kumar, Donna L. Barnd, et al.. (1992). Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T lymphocytes that recognize immunodominant epitopic peptides from Plasmodium falciparum and HIV-1. The Journal of Immunology. 149(4). 1311–1318. 22 indexed citations
7.
Groot, Anne S. De, Mario Clerici, Anne Hosmalin, et al.. (1991). Human Immunodeficiency Virus Reverse Transcriptase T Helper Epitopes Identified in Mice and Humans: Correlation with a Cytotoxic T Cell Epitope. The Journal of Infectious Diseases. 164(6). 1058–1065. 26 indexed citations
8.
Jerome, Keith R., Donna L. Barnd, Katharine M. Bendt, et al.. (1991). Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.. PubMed. 51(11). 2908–16. 305 indexed citations
9.
Barnd, Donna L., Michael S. Lan, Richard S. Metzgar, & Olivera J. Finn. (1989). Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.. Proceedings of the National Academy of Sciences. 86(18). 7159–7163. 379 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026